Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease pulmonary arterial hypertension
Comorbidity |congenital heart disease
Sentences 52
PubMedID- 21893489 pulmonary arterial hypertension associated with congenital heart disease (pah-chd) using three different response criteria.
PubMedID- 24814894 Blood biomarkers and their potential role in pulmonary arterial hypertension associated with congenital heart disease.
PubMedID- 21943933 Efficacy and safety of bosentan for pulmonary arterial hypertension in adults with congenital heart disease.
PubMedID- 22781765 [screening study of pulmonary arterial hypertension in patients with congenital heart diseases].
PubMedID- 26135803 Riociguat for pulmonary arterial hypertension associated with congenital heart disease.
PubMedID- 24629043 Apah-chd: pulmonary arterial hypertension associated with congenital heart disease; apah-ctd: pulmonary arterial hypertension associated with connective tissue disease; ci: confidence interval; hr: hazard ratio; mpap: mean pulmonary arterial pressure; nyha: new york heart association; pah: pulmonary arterial hypertension; pcwp: pulmonary capillary wedge pressure; rhc: right heart catheterization; sd: standard deviation; 6mwd: 6-minute walk distance.
PubMedID- 25549894 Eisenmenger's syndrome (es) is the most advanced form of pulmonary arterial hypertension (pah) associated with congenital heart diseases (chd).
PubMedID- 25650280 The progressive rise in pulmonary vascular resistance and increased pressures in the right heart provocated reversal of the shunt may arise with the development of eisenmenger' syndrome the most advanced form de pulmonary arterial hypertension associated with congenital heart disease.
PubMedID- 23052666 This study enrolled 29 congenital heart disease cases with pulmonary arterial hypertension and 40 healthy subjects followed at our center.
PubMedID- 26413109 Background and objectives: despite remarkable advances in pediatric cardiology, pulmonary arterial hypertension associated with congenital heart disease remains a major problem.
PubMedID- 25604592 pulmonary arterial hypertension associated with congenital heart disease and eisenmenger syndrome: current practice in pediatrics.
PubMedID- 25362943 Objectives: eisenmenger syndrome (es) occurs as the most advanced form of pulmonary arterial hypertension (pah) in patients with congenital heart disease.
PubMedID- 23041100 Efficacy of exercise training in pulmonary arterial hypertension associated with congenital heart disease.
PubMedID- 20549685 pulmonary arterial hypertension associated with congenital heart disease (apah-chd) (n = 61, 34%) was more common than idiopathic pah (ipah) (n = 36, 20%).
PubMedID- 23962785 Background: eisenmenger syndrome (es) represents the extreme manifestation of pulmonary arterial hypertension in patients with congenital heart disease, associated with significant exercise intolerance and mortality.
PubMedID- 20875358 pulmonary arterial hypertension frequently arises in patients with congenital heart disease.
PubMedID- 25737007 This study investigated the clinical value of plasma asymmetrical dimethyl-l-arginine (adma) level in the diagnosis, staging, and treatment response in congenital heart disease (chd) patients with pulmonary arterial hypertension (pah).
PubMedID- 24081196 Objectives: the treatment of choice for congenital heart disease (chd) with pulmonary arterial hypertension (pah) is still controversial.
PubMedID- 25787791 pulmonary arterial hypertension associated with congenital heart disease.
PubMedID- 24267300 pulmonary arterial hypertension associated with congenital heart disease.
PubMedID- 23064558 Comparison of acute hemodynamic effects of aerosolized iloprost and inhaled nitric oxide in adult congenital heart disease with severe pulmonary arterial hypertension.
PubMedID- 24942698 pulmonary arterial hypertension (pah) associated with congenital heart disease (pah-chd) is a common late complication, and is associated with increased morbidity and mortality.
PubMedID- 26459910 We validated our methods by quantifying mirna expression profiles in the sera of the patients with pulmonary arterial hypertension associated with congenital heart disease.
PubMedID- 25006452 Standardization of the diagnostic routine for children with congenital heart disease associated with pulmonary arterial hypertension (pah-chd) is crucial, in particular since inappropriate assignment to repair of the cardiac lesions (e.g., surgical repair in patients with elevated pulmonary vascular resistance) may be detrimental and associated with poor outcomes.
PubMedID- 22340653 Objective: to explore the incidence of congenital heart disease (chd) complicated with pulmonary arterial hypertension (pah) at an altitude of over 2000 meters above sea level.
PubMedID- 25620261 [management of pulmonary arterial hypertension associated with congenital heart disease with specific pulmonary arterial hypertension vasoactive drugs combined with transcatheter closure strategy:a case report].
PubMedID- 25076993 Saudi guidelines on the diagnosis and treatment of pulmonary hypertension: pulmonary arterial hypertension associated with congenital heart disease.
PubMedID- 25443244 pulmonary arterial hypertension associated with congenital heart disease: recent advances and future directions.
PubMedID- 22068906 Plasma von willebrand factor as a predictor of survival in pulmonary arterial hypertension associated with congenital heart disease.
PubMedID- 20728407 Introduction: traditionally, treatment options for patients with pulmonary arterial hypertension associated with congenital heart disease (pah-chd) are limited.
PubMedID- 23720182 [pulmonary arterial hypertension in patients with congenital heart disease: current issues and health care situation].
PubMedID- 24790070 Objectives: to assess the relationship of c-reactive protein (crp) to clinical outcome and mortality in adults with pulmonary arterial hypertension (pah) associated with congenital heart disease (chd-pah).
PubMedID- 23895034 The challenge of managing pulmonary arterial hypertension in adults with congenital heart disease.
PubMedID- 24176071 Uncorrected congenital heart disease (chd) frequently leads to pulmonary arterial hypertension (pah), the most severe form of which is eisenmenger syndrome (es).
PubMedID- 25847058 Methods: using micrornas microarray, we profiled the micrornas in the lung specimen from 12 congenital heart disease patients, (6 with pulmonary arterial hypertension and the others without).
PubMedID- 21093377 A review of the management of pulmonary arterial hypertension associated with congenital heart disease.
PubMedID- 23204121 pulmonary arterial hypertension associated with congenital heart disease.
PubMedID- 24225339 Assessment of operability of patients with pulmonary arterial hypertension associated with congenital heart disease.
PubMedID- 22257586 However, it is particularly useful in patient with pulmonary arterial hypertension associated with congenital heart disease.
PubMedID- 25224243 [correlation between endogenous sulfur dioxide and homocysteine in children with pulmonary arterial hypertension associated with congenital heart disease].
PubMedID- 19958396 pulmonary arterial hypertension in adults with congenital heart disease.
PubMedID- 21723630 pulmonary arterial hypertension (pah) associated with congenital heart disease (chd) due to systemic to pulmonary shunting is associated with a high risk of morbidity and mortality.
PubMedID- 25410917 [a cross-sectional study of pulmonary arterial hypertension in congenital heart disease by right heart catheterization].
PubMedID- 23351920 However, its long-term efficacy and safety in patients with pulmonary arterial hypertension (pah) associated with complex congenital heart disease (chd) is unknown.
PubMedID- 20143207 Data sources: articles on pulmonary arterial hypertension in congenital heart disease were retrieved from pubmed and medline published after 1958.
PubMedID- 24577356 Right ventricular diastolic performance in children with pulmonary arterial hypertension associated with congenital heart disease: correlation of echocardiographic parameters with invasive reference standards by high-fidelity micromanometer catheter.
PubMedID- 24571873 Background: congenital heart disease with severe pulmonary arterial hypertension (spah), previously thought to have irreversible pulmonary vascular disease (pvd), has been recently successfully corrected using diagnostic treatment and repair strategy by our surgery team.
PubMedID- 23280192 Objective: the aim of this study is to determine the relationship between the cardiac catheterization findings and pulsed-wave (pw) doppler and doppler tissue imaging (dti) in pulmonary arterial hypertension patients with congenital heart disease with intracardiac shunts.
PubMedID- 23640439 Accuracy of doppler echocardiography in the assessment of pulmonary arterial hypertension in patients with congenital heart disease.
PubMedID- 24093869 Value of systolic right ventricular function parameters in children with pulmonary arterial hypertension associated with congenital heart diseases.

Page: 1 2